Stem, Inc. (STEM) has disclosed a new risk, in the Share Price & Shareholder Rights category.
Stem, Inc. faces a significant risk of failing to meet the NYSE’s continued listing criteria as its stock price has fallen below the required threshold. This non-compliance threatens the company’s ability to maintain its NYSE listing, which could lead to a decrease in market confidence, reduced liquidity, and increased trading restrictions if not rectified. The potential delisting may also diminish the company’s ability to attract investors and secure future financing. Despite notifying the NYSE of its intent to regain compliance, there is no guarantee that Stem, Inc. will succeed within the allocated cure period.
The average STEM stock price target is $1.26, implying 233.77% upside potential.
To learn more about Stem, Inc.’s risk factors, click here.
